Ceftazidime
Who holds supplier records for Ceftazidime? 7 organisations hold a current record for Ceftazidime: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (2), India (1), China (1), South Korea (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Ceftazidime: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ceftazidime
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Ceftazidime. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ACS DOBFAR SPAItalyCEP Company GMP cert on recordActive DMF 17628 · latest filing Aug 2004
- FRESENIUS KABI IPSUM SRLItalyCEP Company GMP cert on recordActive DMF 38741 · latest filing Dec 2023
- Orchid Pharma LimitedIndiaCEP Company GMP cert on recordActive DMF 23294 · latest filing Dec 2009
- GLAXOSMITHKLINE LLCActive DMF 24339 · latest filing Mar 2011
- Qilu Antibiotics Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on record
- HANMI FINE CHEMICAL CO., LTD.South KoreaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- SANDOZ GMBHAustriaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Ceftazidime, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 10 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ACS DOBFAR S.P.A. Tribiano | IT | CEP 2023-299 - Rev 01 Ceftazidime Pentahydrate, Sterile | Jun 2026 | — |
| ORCHID PHARMA LIMITED Alathur | IN | CEP 2005-028 - Rev 05 Ceftazidime Pentahydrate, Sterile | Sept 2024 | Inspected Oct 2024 Poland |
| HANMI FINE CHEMICAL CO., LTD. Siheung-si | KR | R1-CEP 2002-069 - Rev 07 Ceftazidime Pentahydrate, Sterile | Jun 2023 | — |
| FRESENIUS KABI IPSUM S.R.L. Cassina de’ Pecchi | IT | R1-CEP 2004-129 - Rev 07 Ceftazidime Pentahydrate, Sterile | May 2023 | — |
| Qilu Antibiotics Pharmaceutical Co., Ltd. Jinan | CN | R1-CEP 2016-195 - Rev 00 Ceftazidime Pentahydrate, Sterile | Nov 2022 | — |
| SANDOZ GMBH Kundl | AT | R1-CEP 2001-252 - Rev 04 Ceftazidime Pentahydrate, Sterile | Jun 2015 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Ceftazidime are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- Kyongbo Pharmaceutical Co., Ltd.South · Inactive DMF 25710 · filed Dec 2011
- India · Inactive DMF 19644 · filed Jul 2006
- GLAXO WELLCOME INCInactive DMF 13650 · filed Aug 2000
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Ceftazidime is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL44354).
Chemical identity
- IUPAC name
- (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Canonical SMILES
- CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]
- InChIKey
- ORFOPKXBNMVMKC-DWVKKRMSSA-N
- Synonyms
- Ceftazidima, Ceftazidime, Ceftazidime anhydrous, Ceftazidime (arginine formulation), Ceftazidime component of avycaz, Ceftazidime component of zavicefta, Ceftazidime hydrate, Ceftazidime pentahydrate, Ceptaz, Fortam, Fortaz, Fortum
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cephalosporin Antibacterial
- Chemical structure
- Cephalosporins
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Ceftazidime?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Ceftazidime: ACS DOBFAR SPA (Italy), FRESENIUS KABI IPSUM SRL (Italy), Orchid Pharma Limited (India), GLAXOSMITHKLINE LLC, Qilu Antibiotics Pharmaceutical Co., Ltd. (China), HANMI FINE CHEMICAL CO., LTD. (South Korea) and SANDOZ GMBH (Austria). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Ceftazidime Drug Master Files are active?
ACS DOBFAR SPA (DMF 17628), FRESENIUS KABI IPSUM SRL (DMF 38741), Orchid Pharma Limited (DMF 23294) and GLAXOSMITHKLINE LLC (DMF 24339). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Ceftazidime records mean?
3 organisations have only inactive Type II DMFs for Ceftazidime. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Ceftazidime have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Ceftazidime on the EDQM register, including ACS DOBFAR S.P.A. Tribiano (IT), ORCHID PHARMA LIMITED Alathur (IN), HANMI FINE CHEMICAL CO., LTD. Siheung-si (KR), FRESENIUS KABI IPSUM S.R.L. Cassina de’ Pecchi (IT), Qilu Antibiotics Pharmaceutical Co., Ltd. Jinan (CN) and SANDOZ GMBH Kundl (AT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Ceftazidime supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Ceftazidime?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.